Evotec Ag (Adr) (EVO) has released an update.
Evotec SE, a biotechnology company, has disclosed a major holding notification, revealing that T. Rowe Price Group, Inc. has crossed the threshold, now owning 12.01% of the voting rights. This marks an increase from a previous holding of 10.11%, indicating a significant acquisition of shares by the U.S.-based global investment management firm. The notification, triggered by a voluntary group notification at the subsidiary level, comes in the midst of a growing interest from major investors in the biotech sector.
For further insights into EVO stock, check out TipRanks’ Stock Analysis page.
